Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Arpita, Nag"'
Autor:
Arpita Nag, Beverly Romero
Publikováno v:
Health and Quality of Life Outcomes, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background Ulcerative colitis (UC) and Crohn’s disease (CD) are associated with a range of symptoms that adversely affect health-related quality of life. This research aimed to develop and validate two patient-reported outcome (PRO) tools
Externí odkaz:
https://doaj.org/article/bcac425f6f1342a481a5f83c01d16667
Publikováno v:
Drugs in Context, Vol 9, Pp 1-7 (2020)
Background: Chronic idiopathic constipation (CIC) is a common gastrointestinal disorder in community settings. Limited information exists on its treatment with the prosecretory agents linaclotide and lubiprostone. This retrospective cohort study inve
Externí odkaz:
https://doaj.org/article/0f3e6d87c62344febfe71271be2c2083
Autor:
Tatiana Makhinova, Jamie C. Barner, Carolyn M. Brown, Kristin M. Richards, Karen L. Rascati, Arpita Nag
Publikováno v:
Pharmacy, Vol 10, Iss 1, p 34 (2022)
Community pharmacist interventions can assist in improving adherence in patients with asthma. The objective of the study was to assess the feasibility of patient-centered counseling using the developed asthma-specific tools to identify barriers to ad
Externí odkaz:
https://doaj.org/article/02b9dceff0aa484fb71bca9bd58461b0
Autor:
Lawrence D. Sher, Giovanni Passalacqua, Camille Taillé, Lauren Cohn, Nadia Daizadeh, Nami Pandit-Abid, Xavier Soler, Angela Khodzhayev, Juby A. Jacob-Nara, Yamo Deniz, Paul J. Rowe, Arpita Nag, Yi Zhang
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology.
Severe asthma impacts quality of life (QoL), including dyspnea, sleep, and activity limitation. Dupilumab, a fully human monoclonal antibody, blocks the shared receptor component for interleukins-4/-13, key and central drivers of type 2 inflammation.
Publikováno v:
Quality of Life Research
Purpose Studies of patients with ulcerative colitis (UC) report that reduced clinical symptoms and endoscopic activity predict better health-related quality of life (HRQoL). However, no study has examined the joint and unique associations of clinical
Autor:
Jonathan Spergel, Juby Jacob-Nara, Evan Dellon, Zhen Chen, Tiffany Pela, Angela Khodzhayev, Arpita Nag, Danen Cunoosamy, Amr Radwan, Siddhesh Kamat, Eilish McCann
Publikováno v:
American Journal of Gastroenterology. 117:e282-e283
Autor:
Mirna Chehade, Andrew J. Epstein, Eilish McCann, Sarette T. Tilton, Arpita Nag, Chao Chen, Degang Wang, Tiffany Pela, Angela Khodzhayev, Ryan Thomas
Publikováno v:
American Journal of Gastroenterology. 117:e274-e275
Publikováno v:
Drugs in Context, Vol 9, Pp 1-7 (2020)
Drugs in Context
Drugs in Context
Background: Chronic idiopathic constipation (CIC) is a common gastrointestinal disorder in community settings. Limited information exists on its treatment with the prosecretory agents linaclotide and lubiprostone. This retrospective cohort study inve
Autor:
Renu M. Vekaria, Deirdre Mladsi, Molly Purser, Arpita Nag, Susan A Martin, Oyebimpe Olayinka-Amao
Publikováno v:
Clinical and Experimental Gastroenterology. 13:255-265
Background Chronic idiopathic constipation (CIC) is a functional gastrointestinal disorder with an estimated prevalence of 16% in the USA; however, the humanistic and economic burden of CIC is poorly characterized. Aim This systematic literature revi
Autor:
Sun Jung Oh, Carine Khalil, Garth Fuller, Devin Patel, William Spalding, Brennan Spiegel, Arpita Nag, Christopher V. Almario
Publikováno v:
The American Journal of Gastroenterology
OBJECTIVES: Chronic idiopathic constipation (CIC) is characterized by unsatisfactory defecation and difficult or infrequent stools. CIC affects 9%–20% of adults in the United States, and although prevalent, gaps in knowledge remain regarding CIC he